Contribution of anticoagulant cabinets to the management of direct oral anticoagulant therapy in patients with atrial fibrillation

Authors: Gyulmamedova S.M., Berdibekov B.Sh., Bulaeva N.I., Kubova М.Ch., Golukhova Е.Z.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2024-18-3-269-277

For citation: Gyulmamedova S.M., Berdibekov B.Sh., Bulaeva N.I., Kubova М.Ch., Golukhova Е.Z. Anticoagulant cabinets in the management of direct oral anticoagulant therapy in patients with atrial fibrillation. Creative Cardiology. 2024; 18 (3): 269–277 (in Russ.). DOI: 10.24022/1997-3187-2024-18-3-269-277

Received / Accepted:  06.05.2024 / 23.07.2024

Keywords: anticoagulant cabinet anticoagulation clinic atrial fibrillation direct oral anticoagulants



Subscribe 🔒

 

Abstract

Anticoagulant therapy is an integral part of the treatment of patients with atrial fibrillation (AF), aimed at preventing thromboembolic complications and fatal outcomes. One of the most serious consequences of taking anticoagulants is hemorrhagic complications. The development and integration into clinical practice of optimal anticoagulant management programs will allow for patient-oriented therapy for both AF and other conditions requiring anticoagulant therapy, reducing the risk of adverse effects and reducing healthcare costs. In this review, we would like to highlight the challenges that exist in treating patients with AF while taking direct oral anticoagulants (DOACs) and how they can be addressed by describing practical models of anticoagulation units or clinics (ACCs) that are integrated into traditional admission international normalized relations monitoring services warfarin, thereby creating a network of new DOAC therapy management services.

References

  1. Elliott A.D., Middeldorp M.E., Van Gelder I.C., Albert C.M., Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat. Rev. Cardiol. 2023; 20 (6): 404–417. DOI: 10.1038/s41569-022-00820-8
  2. Bockeria L.A., Bzhikshiev Z.Yu. Pathophysiological mechanisms and therapeutic management of cognitive impairment in patients with atrial fibrillation. Annaly Aritmologii (Annals of Arrhythmology). 2020; 17 (1): 38–45 (in Russ.). DOI: 10.15275/annaritmol.2020.1.5
  3. Bockeria L.A., Bockeria O.L., Kanametov T.N., Shvartz V.A. The randomized study of epicardial application of hydrogel with amiodarone for prevention of postoperative atrial fibrillation in patients after coronary artery bypass grafting. Annaly Aritmologii (Annals of Arrhythmology). 2018; 15 (4): 196–203 (in Russ.). DOI: 10.15275/annaritmol.2018.4.1
  4. Kanametov T.N., Panagov Z.G., Averina I.I. The relationship between the development of postoperative atrial fibrillation and the level of interleukin-6 in patients undergoing coronary bypass surgery. Annaly Aritmologii (Annals of Arrhythmology). 2023; 20 (1): 34–42 (in Russ.). DOI: 10.15275/annaritmol.2023.1.4
  5. Garay O.U., Guinazu G., Adamczuk Y.P., Duboscq C. Cost-utility and budget impact analysis of implementing anticoagulation clinics and point-of-care monitoring devices in anticoagulated patients in argentina. Pharmacoecon. Open. 2022; 6 (5): 657–668. DOI: 10.1007/ s41669-022-00352-4
  6. Ceresetto J.M., Duboscq C., Korin J., Fondevila C., Casais P., Rossi A. et al. Argentine consensus in effective management of anticoagulation clinics for the use of vitamin K antagonists. Medicina (B. Aires). 2020; 80 (4): 1–26.
  7. Lopez-Lopez J.A., Sterne J.A.C., Thom H.H.Z., Higgins J.P.T., Hingorani A.D., Okoli G.N. et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017; 359: j5058. DOI: 10.1136/bmj. j5058
  8. Sylvester K.W., Ting C., Lewin A., Collins P., Fanikos J., Goldhaber S.Z. et al. Expanding anticoagulation management services to include direct oral anticoagulants. J. Thromb. Thrombolysis. 2018; 45 (2): 274–280. DOI: 10.1007/s11239-017-1602-1
  9. Vorobyeva N.A., Vorobyeva A.I., Shemiakina N.Ya., Alexeeva A.S. Patient-centered approach as a basis for efficiency and safety improvement of antithrombotic therapy in patients with comorbidity – role of anticoagulant cabinets. Clin. Gerotntol. 2019; 25 (11–12): 19–24 (in Russ.). DOI: 10.26347/1607-2499201911-12019-024
  10. Trujillo T.C., Dobesh P.P., Crossley G.H., Finks S.W. Contemporary managem ent of direct oral anticoagulants during cardioversion and ablation for nonvalvular atrial fibrillation. Pharmacotherapy. 2019; 39 (1): 94–108. DOI: 10.1002/phar.2205
  11. Anakwue R. Moving towards ideal and appropriate models of anticoagulation management service. Ann. Afr. Med. 2020; 19 (3): 153–163. DOI: 10.4103/aam.aam_30_19
  12. Antonov I.M., Aristov E.G., Sychev D.A., Kuznetsov A.B., Tashenova A.I., Kukes V.G. Anticoagulant clinics: foreign experience and prospects for Russian healthcare. Creative Cardiology. 2010; 4 (1): 35–42 (in Russ.).
  13. Rogozina A.S., Vorobyova N.A. Experience of anticoagulant clinic’s work in Arkhangelsk. Human Ecology. 2012; 19 (12): 59–64 (in Russ.). DOI: 10.17816/humeco17410
  14. Safin D.D., Galimzyanov A.F., Slyuter M. Specialized software in the management of anticoagulant therapy network in the Republic of Tatarstan. Russian Journal of Preventive Medicine (Profilakticheskaya Meditsina). 2021; 24 (10): 32–38 (in Russ.). DOI: 10.17116/ profmed20212410132
  15. Salpagarova Z.К., Andreev D.A., Sichev D.A., Bikova A.A., Syrkin S.A., Suchkova S.A. Anticoagulant therapy control in primary healthcare setting. Sechenov Medical Journal. 2016; 2 (24): 8–12 (in Russ.)
  16. Baldoni S., Amenta F., Ricci G. Tele-pharmacy services: present status and future perspectives: a review. Medicina (Kaunas). 2019; 55 (7): 327. DOI: 10.3390/medicina55070327
  17. Zhang C., Pan M.M., Wang N., Wang W.W., Li Z., Gu Z.C. et al. Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study. Eur. J. Clin. Pharmacol. 2022; 78 (2): 293–304. DOI: 10.1007/s00228-021-03236-4
  18. Valencia D., Spoutz P., Stoppi J., Kibert J. L., Allen A., Parra D. et al. Impact of a direct oral anticoagulant population management tool on anticoagulation therapy monitoring in clinical practice. Ann. Pharmacother. 2019; 53 (8): 806–811. DOI: 10.1177/1060028019835843
  19. Sylvester K.W., Chen A., Lewin A., Fanikos J., Goldhaber S.Z., Connors J.M. Optimization of DOAC management services in a centralized anticoagulation clinic. Res. Pract. Thromb. Haemost. 2022; 6 (3): e12696. DOI: 10.1002/rth2.12696
  20. Jones A.E., King J.B., Kim K., Witt D.M. The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring. J. Thromb. Thrombolysis. 2020; 50 (3): 739–745. DOI: 10.1007/s11239-020-02064-5

About Authors

  • Sayali M. Gyulmamedova, Postgraduate; ORCID
  • Bektur Sh. Berdibekov, Junior Researcher, Cardiologist; ORCID
  • Naida I. Bulaeva, Cand. Biol. Sci., Associate Professor, Head of Department, Cardiologist; ORCID
  • Maida Ch. Kubova, Researcher, Cardiologist; ORCID
  • Elena Z. Golukhova, Dr. Med. Sci., Professor, Academician of RAS, Director; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery